drugset / Trial / NCT00002898

Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma

NCT00002898 ↗

Phase 3 Completed 400 enrolled International Society of Pediatric Oncology
RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one chemotherapy drug with surgery and/or radiation therapy may kill more tumor cells. PURPOSE: This randomized phase III trial is studying surgery followed by different regimens of combination chemotherapy given together with radiation therapy and/or additional surgery to compare how well they work in treating patients with soft tissue sarcoma.

Timeline

Start
1995-01
Primary completion
—
Completion
2009-12

Outcome

Missed primary endpoint

paper No significant difference in outcome in either OS or event-free survival was noted between the two arms PMID 22665534 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — —
Subject Epirubicin Small molecule — —
Subject Etoposide Small molecule — —
Background Cyclophosphamide Other / unclassified — —
Background Dactinomycin Unknown — —
Background Ifosfamide Small molecule — —
Background Vincristine Small molecule — —